Showing results (641-650 of 1,343) with videos related to

Sort By:
Pageof 135
The Pharmacogenomics Journal|September 9, 2023
The INGENIOUS trial: Impact of pharmacogenetic testing on adverse events in a pragmatic clinical trialMichael T Eadon, Marc B Rosenman, Pengyue Zhang, et al.
The Pharmacogenomics Journal|March 10, 2026
Computational variant predictors for pharmacogenomics: from evaluation of single alleles to assessment of adverse drug reactions to antidepressantsJacek Hajto, Marcin Piechota, Ilse Krätschmer, et al.
The Pharmacogenomics Journal|April 29, 2026
CYPRI: a clinical decision-making tool to select psychiatric patients for pharmacogenetic testingIvana Tašková, Nicole Šafářová, Martina Hahn
The Pharmacogenomics Journal|April 20, 2026
Cost-effectiveness of genotype-guided acenocoumarol therapy in atrial fibrillation: a pharmacogenomic simulation study in the chilean populationMaximiliano Mena, Matías Carrasco, Leslie C Cerpa, et al.
The Pharmacogenomics Journal|April 23, 2026
Cardiovascular prescriber attitudes to pharmacogenomics: a survey by the ESC working group on cardiovascular pharmacotherapyEmma F Magavern, G-Andrei Dan, Gianluigi Savarese, et al.
The Pharmacogenomics Journal|May 25, 2026
Cost-effectiveness analysis of encorafenib in untreated BRAF V600E-mutant metastatic colorectal cancer in ChinaShaohong Luo, Yijun Cai, Xiangzhen Wang, et al.
The Pharmacogenomics Journal|May 21, 2026
Impact of population-specific pharmacogenomic variants on drug dosing in ICU patientsMahboubeh R Rostami, Juan Rodriguez-Flores, Ali Ait Hssain, et al.
The Pharmacogenomics Journal|June 6, 2026
Cost-effectiveness of genome-guided statin treatment for hypercholesterolemiaMargarita-Ioanna Koufaki, Korina Tzerefou, Achilleas Tyrovolas, et al.
The Pharmacogenomics Journal|December 8, 2010
CYP2D6 genotype and debrisoquine hydroxylation phenotype in Cubans and NicaraguansA Llerena, P Dorado, R Ramírez, et al.
The Pharmacogenomics Journal|June 29, 2026
Toxicity related to immunotherapy in urothelial cancer: Tumour genetic risk variantsJ M Rodríguez-Piñas, A Romero-Lorca, A Novillo, et al.
Pageof 135